Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-010884
Filing Date
2015-02-09
Accepted
2015-02-09 17:07:32
Documents
1
Period of Report
2015-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4027
  Complete submission text file 0001209191-15-010884.txt   5474
Mailing Address 65 HAYDEN AVE LEXINGTON MA 02421
Business Address
GUIFFRE CHRISTOPHERD T (Reporting) CIK: 0001219021 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 15589371

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations